- Investing Ideas
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
1 new
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €333.7m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€18.88
7D
6.7%
1Y
-37.7%
MPH Health Care
Market Cap: €101.5m
An investment company, engages in the healthcare business in Germany.
New
93M1
€23.50
7D
-6.0%
1Y
31.7%
Novogenia
Market Cap: €80.4m
Manufactures and sells personalized health products in global markets.
7V0
€6.70
7D
3.1%
1Y
-8.2%
Cantourage Group
Market Cap: €68.3m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€5.48
7D
2.6%
1Y
29.9%